September 2026
September 2026 | Oncology
Cancer-Associated Retinopathy With Thymic Carcinoma
A multimodal approach to treatment led to meaningful visual improvement despite poor prognostic signs on OCT.
Mena Kozman, MD; Aaron Shi, MD; Nyaari Kothiya; Sami Dahr, MD; and Rabia Karani, MD, MPH
September 2026 | Features
Can OCTA Help Predict DR Progression?
Quantitative biomarkers may add a new dimension to the assessment and risk stratification of diabetic retinopathy.
Kallista Zhuang, BA; Shinji Kakihara, MD, PhD; and Amani A. Fawzi, MD
September 2026 | Features
AI in DME: From Promise to Clinical Practice
New data show the growing utility of AI-assisted screening, referrals, and treatment response prediction.
Scott Song, BA, and T. Y. Alvin Liu, MD
September 2026 | Global Perspectives
Scleral Dehiscence Following PPV in a Patient With Marfan Syndrome
Consider a surgical approach that can better accommodate a thin sclera in patients with this connective tissue disorder.
Hind Safi, MD; Younes Tlemçani, MD, PhD; Sarah Belghmaidi, MD, PhD; and Abdeljalil Moutaouakil, MD, PhD
Popular Articles
March 2026 Supplement | Digital Supplement
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
March 2026 | Meeting Minutes
ACRC and Macula 2026: A Summary
The annual meeting boasted top-notch clinical and surgical education, honored guests, and comradery.
Justin C. Muste, MD; Collin Richards, MD; Timothy Xu, MD; and Erik Massenzio, MD
September 2026 | Visually Speaking
A Patch With Potential
An amniotic membrane transplant was used to treat a patient with chronic, complex macular hole.
Osama M. Ahmed, MD, and Mohsin H. Ali, MD